Brief: Extrawell Pharmaceutical Says Guo Yi Redesignated To An Executive Director
07/06/2024 18:20
June 7 (Reuters) - Extrawell Pharmaceutical Holdings Ltd
0858.HK :
* GUO YI REDESIGNATED TO AN EXECUTIVE DIRECTOR
Further company coverage: 0858.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Extrawell Pharmaceutical Holdings
See all newsBrief: Extrawell Pharmaceutical Abandons Negotiations For Possible Sale Of Convertible Bonds
Brief: Extrawell Pharmaceutical Proposes Share Consolidation Of 20 Shares Into 1 Share Of HK$0.20 Par Value
Brief: Extrawell Pharmaceutical Says Mr. Wu Xiangyun Appointed As Executive Director
Brief: Extrawell Pharmaceutical Expects FY Loss Of At Least HK$950 Million
Brief: Extrawell Pharmaceutical's Unit To Buy Back 10.06% Of Its Stake For RMB4.4 Million